SOAFEE, Inc. (SOFE)
OTCMKTS · Delayed Price · Currency is USD
0.0011
0.00 (0.00%)
At close: Aug 11, 2025
SOAFEE Revenue
SOAFEE had revenue of $1.46M in the quarter ending December 31, 2022, with 1,383.14% growth. This brings the company's revenue in the last twelve months to $2.23M, up 876.28% year-over-year. In the year 2022, SOAFEE had annual revenue of $1.46M with 372.16% growth.
Revenue (ttm)
2.23M
Revenue Growth
+876.28%
P/S Ratio
0.02
Revenue / Employee
222.51K
Employees
10
Market Cap
34.82K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 1.46M | 1.15M | 372.16% |
Dec 31, 2021 | 310.14K | - | - |
Dec 31, 2012 | - | - | - |
Dec 31, 2011 | - | - | - |
Dec 31, 2010 | 58.11K | -2.13M | -97.34% |
Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |